The efficiency of benzodiazepines on mouse model of anticholinesterase poisoning was shown. The protective effects of clonazepam and midazolam were observed at high (1 TD50, incoordination) and medium (0.3 TD50) doses and the effects of phenazepam and diazepam were found only at high doses. Midazolam produced the most pronounced protective effect: administration of this drug significantly increased the protective index of atropine+HI-6 combination during poisoning.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s10517-013-2152-y | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Gabaergic sedative prospection of sclareol-linalool co-treatment: An antagonistic intervention through in vivo and in silico studies.
Neurosci Lett
January 2025
Department of Biological Chemistry, Regional University of Cariri, Crato 63105-000, Brazil. Electronic address:
Sleep disturbance causes many health problems in humans worldwide. This study evaluated the effects and possible mechanisms of sclareol (SCL) and/or linalool (LIN) through in vivo and in silico studies. For this, young chicks SCL (5, 10, and 20 mg/kg) and/or LIN (50 mg/kg) were orally administered thirty minutes before to the thiopental sodium (TS)-induced chicks with or without the standard drug diazepam (DZP: 3 mg/kg).
View Article and Find Full Text PDFMidazolam - A diazepam replacement for the management of nerve agent-induced seizures.
Neuropharmacology
December 2024
University of Defence, Military Faculty of Medicine, Department of Toxicology and Military Pharmacy, Trebesska 1575, 500 01, Hradec Kralove, Czech Republic; University Hospital Hradec Kralove, Biomedical Research Centre, Sokolska 581, 500 05, Hradec Kralove, Czech Republic.
Article Synopsis
- Diazepam has been the main treatment for seizures caused by toxic nerve agents since the 1960s, but its limitations have raised concerns, leading to research on alternative medications.
- Two significant alternatives that have advanced in clinical use are Avizafone and intramuscular midazolam, the latter recently approved by the FDA, offering benefits like rapid action and better solubility.
- While midazolam shows promise as a more effective treatment for poisoned casualties, its sedative effects pose challenges in determining the right dosage for soldiers in combat situations.
Ligands of the trace amine-associated receptors (TAARs): A new class of anxiolytics.
Pharmacol Biochem Behav
September 2024
Institute of Translational Biomedicine, St. Petersburg State University, 199034 St. Petersburg, Russia; St. Petersburg University Hospital, St. Petersburg State University, 199034 St. Petersburg, Russia. Electronic address:
Most cases of anxiety are currently treated with either benzodiazepines or serotonin reuptake inhibitors. These drugs carry with them risks for a multitude of side effects, and patient compliance suffers for this reason. There is thus a need for novel anxiolytics, and among the most compelling prospects in this vein is the study of the TAARs.
View Article and Find Full Text PDFVariation in Sedative and Analgesic Use During the COVID-19 Pandemic and Associated Outcomes.
CHEST Crit Care
March 2024
Division of Health Systems Science, Department of Medicine, University of Massachusetts Chan School of Medicine, Worcester MA.
Background: Providing analgesia and sedation is an essential component of caring for many mechanically ventilated patients. The selection of analgesic and sedative medications during the COVID-19 pandemic, and the impact of these sedation practices on patient outcomes, remain incompletely characterized.
Research Question: What were the hospital patterns of analgesic and sedative use for patients with COVID-19 who received mechanical ventilation (MV), and what differences in clinical patient outcomes were observed across prevailing sedation practices?
Study Design And Methods: We conducted an observational cohort study of hospitalized adults who received MV for COVID-19 from February 2020 through April 2021 within the Society of Critical Care Medicine Discovery Viral Infection and Respiratory Illness Universal Study (VIRUS) COVID-19 Registry.
Investigation of the cytotoxicity, genotoxicity and antioxidant prospects of JM-20 on human blood cells: A multi-target compound with potential therapeutic applications.
Blood Cells Mol Dis
May 2024
Programa de Pós-graduação em Ciências Biológicas: Bioquímica Toxicológica, Universidade Federal de Santa Maria, 97105-900 Santa Maria, RS, Brazil. Electronic address:
Article Synopsis
- - The study investigates the cytotoxic effects of JM-20, a compound potentially harmful to blood cells, by assessing cell viability, morphology changes, and oxidative stress in human leukocytes and erythrocytes.
- - Results showed that while low concentrations (10 μM) of JM-20 had a cytoprotective effect, higher concentrations (20 and 50 μM) significantly decreased leukocyte viability and increased reactive species levels, indicating potential toxicity.
- - JM-20 demonstrated strong antioxidant properties comparable to α-tocopherol, effectively reducing lipid peroxidation and DPPH radical levels, without causing significant hemolysis, cell cycle changes, or DNA damage.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!